Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingrun refers to a proprietary traditional Chinese medicine formula available in various forms, including capsules and pills, such as the Jinju Qingrun capsule and Qingrun Pills. It is commonly used in China for the treatment of conditions such as Sjogren’s syndrome, where it is administered to relieve symptoms like xerostomia (dry mouth) and dry eyes[4][5]. The composition typically involves herbal ingredients (specific composition is not provided in the current sources), and its mechanism of action is associated with the modulation of immune responses in autoimmune disorders, according to traditional Chinese medicine principles. It is orally administered and shows clinical benefit for symptom relief in Sjogren’s syndrome when used alone or in combination with conventional Western medicines[4]. There is no evidence of direct pharmaceutical mechanisms or molecular targets characteristic of modern pharmacological agents in the available literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingrun.